The global immuno-oncology assays market is estimated to be valued at US$3,718.5 Mn in 2021 and is expected to exhibit a CAGR of 10.7% over the forecast period 2022-2028.

A) Market Overview:

The immuno-oncology assays market is witnessing significant growth due to the increasing research and development in cancer immunotherapy. Immuno-oncology assays play a crucial role in understanding the interaction between the immune system and cancer cells, which helps in ... Read more

Immuno-oncology assays help in monitoring the levels of cancer biomarkers and T-cell activation markers in cancer patients undergoing immunotherapy treatment. These assays play a vital role in personalized cancer care by helping physicians optimize drug dosing, identify non-responders early, and monitor treatment response and disease progression. The global immuno-oncology assays market provides assays to monitor biomarkers such as PD-L1, IDO1, TIM-3, LAG-3, CTLA-4, and various cytokines ... Read more